↓ Skip to main content

PLOS

Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine

Overview of attention for article published in PLOS ONE, January 2010
Altmetric Badge

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
35 Mendeley
Title
Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine
Published in
PLOS ONE, January 2010
DOI 10.1371/journal.pone.0008816
Pubmed ID
Authors

Sandhya Vasan, Sarah J. Schlesinger, Zhiwei Chen, Arlene Hurley, Angela Lombardo, Soe Than, Phumla Adesanya, Catherine Bunce, Mark Boaz, Rosanne Boyle, Eddy Sayeed, Lorna Clark, Daniel Dugin, Mar Boente-Carrera, Claudia Schmidt, Qing Fang, Ba Lei, Yaoxing Huang, Gerasimos J. Zaharatos, David F. Gardiner, Marina Caskey, Laura Seamons, Martin Ho, Len Dally, Carol Smith, Josephine Cox, Dilbinder Gill, Jill Gilmour, Michael C. Keefer, Patricia Fast, David D. Ho

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Canada 1 3%
South Africa 1 3%
Unknown 32 91%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 17%
Student > Master 4 11%
Student > Bachelor 4 11%
Librarian 2 6%
Other 2 6%
Other 10 29%
Unknown 7 20%
Readers by discipline Count As %
Medicine and Dentistry 8 23%
Agricultural and Biological Sciences 7 20%
Immunology and Microbiology 3 9%
Biochemistry, Genetics and Molecular Biology 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Other 5 14%
Unknown 8 23%